A-share innovative drug stocks rallied, with Yaokang Biotech surging over 13% and Lemei Pharmaceutical rising over 8%. Other stocks such as Yinuosi, Harbin Sanlian Pharmaceutical, Borui Pharmaceutical, Hualan Pharmaceutical, and Zhongsheng Pharmaceutical also saw gains. In related news, US President Trump announced on social media on July 21 that all generic drugs imported into the US will continue to be subject to zero tariffs for two years, starting August 1, 2026. After the two-year period, a 100% tariff will be imposed on these products for one year; thereafter, the tariff will further increase to 200%.